Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects

Cardiovascular Diabetology

Volumn 1, Issue , 2002, Pages

  Lichnovská, Radka ^a   Gwozdziewiczová, Simona ^a   Hrebícek, Jirí ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONSTANTS AND COEFFICIENTS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PREMENOPAUSE; PROTEIN FUNCTION; SEX DIFFERENCE; STATISTICAL ANALYSIS;

EID: 2442718758     PISSN: 14752840     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2840-1-4     Document Type: Article

References (53)

1. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults. JAMA 2002, 287:356-359
2. Isomaa B, Almgren P, Tuomi T, Forsén B, Nissén M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689
3. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1596-1607
4. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity. J Clin Invest 1997, 100:1166-1173
5. Moran A, Jacobs DR, Steinberger J, Hong CP, Prineas R, Luepker R, Sinaiko AR: Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999, 48:2039-2044
6. Meisinger C, Thorand B, Schneider A, Stieber J, Doring A, Lowel H: Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch intern Med 2002, 162:82-89
7. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, et al: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995, 1:1155-1161
8. Hickey NS, Israel RG, Gardiner SN, et al: Gender differences in serum leptin levels in humans. Biochem Mol Med 1996, 59:1-6
9. Haffner SM, Gingerich RL, Miettinen H, Stern MP: Leptin concentrations in relation to overall adiposity and regional fat distribution in Mexican Americans. Int J Obes 1996, 20:904-908
10. Zimmet P, Hodge A, Nicholson M, Straten M, De Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G: Serum leptin concentration, obesity, and insulin resistance in Western Samoans: Cross sectional study. BMJ 1996, 313:965-969
11. Harmelen VV, Reynisdottir S, Eriksson P, Thörne A, Hoffstedt J, Lönnquist F, Arner P: Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998, 47:913-917
12. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997, 46:342-347
13. Tai ES, Lau TN, Ho SC, Fok ACK, Tan CE: Body fat distribution and cardiovascular risk in normal weight women. Association with insulin resistance, lipids and plasma leptin. Intern Latin J of Obesity 2000, 24:751-757
14. Hotamisligil GS, Arner P, Caro JF, Atkinson L, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995, 95:2409-2415
15. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 1995, 95:2111-2119
16. Moller DE: Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000, 11:212-217
17. Couillard C, Meuriége P, Prud'homme D, Nadeau A, Tremblay A, Bouchard C, Després J-P: Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 1997, 40:1178-1184
18. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT: The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J clin Endocrinol Metab 1997, 82:1293-1300
19. Erikkson J, Valle T, LindströM j, Haffner S, Louhernta A, Uusitupa M, Tuomilehto J: Leptin concentrations and theit relation to body fat distribution and weight loss - A prospective study in individuals with impaired glucose tolerance. Horm Metab Res 1999, 31:616-619
20. Hattori A, Uenura K, Miura H, Ueda M, Tamaya N, Iwata F, Muraguchi M, Ohmoto Y, Iguchi A: Gender-related diferrence in relationship between insulin resistance and serum leptin level in Japanese type 2 diabetic and non-diabetic subjects. Endocrine journal (Japan) 2000, 47:615-621
21. Doucet E, St-Pierre S, Alméras N, Mauriége P, Després J-P, Richard D, Bouchard C, Tremblay A: Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: Evidence from both a cross-sectional and intervention study. J Clin Endocrinol Metab 2000, 85:4231-4237
22. Baumgartner RN, Ross RR, Waters DL, Brooks WM, Morley JE, Montoya GD, Garry PJ: Serum leptin in elderly people: associations with sex hormones, insulin, and adipose tissue volumes. Obesity Research 1999, 7:141-149
23. Ruige JB, Dekker JM, Blum WF, Stehouver CD, Nijpels G, Mooy J, Kostense PJ, Bouter LM, Heine RJ: Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care 1999, 22:1097-1104
24. Marshall JA, Grunwald GK, Donahoo WT, Scarbro S, Shetterly SM: Percent body fat and lean mass explain the gender difference in leptin: Analysis and interpretation of leptin in Hispanic and non-Hispanic whitw adults. Obesity Research 2000, 8:543-552
25. Assmann G, Carmena R, Cullen P, Fruchart J-C, Jossa F, Lewis B, Mancini M, Paoletti R: Coronary heart disease: Reducing the risk. Nutrition, metabolism and cardiovascular disease 1998, 8:205-271
26. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Galagher D, Chu F, Leibel RL: Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996, 81:3424-3427
27. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD: Gender differences in plasma leptin concentrations. Nature Med 1996, 2:949-950
28. Schoonjans K, Martin G, Staels B, Auwerx J: Peroxisome proliferator-activated receptors, orphans with ligands and functions. Current Opinion in Lipidology 1997, 8:159-166
29. Martin G, Schoonjans K, Staels B, Auwerx J: PPAR activators improve glucose homeostasis by changing fatty acid partitioning. In: Atherosclerosis XI (Edited by: Jacocot B, Mathé D, Frichart J-C) Elsevier Science, Singapore 1998, 35-47
30. Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK: Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:3159-3163
31. Erkkilä AT, Närvänen O, Lehto S, Uusitupa MIJ, Ylä-Herttuala S: Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2000, 20:204-209
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RL: Homeostasis model assessment: Insulin resistance and β -cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28:412-419
33. Haffner SM, Miettinen H, Stern MP: The homeostasis model in the San Antonio heart study. Diabetes Care 1997, 20:1087-1092
34. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check Index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410
35. Hrebícek J, Janout V, Malincíková J, Horáková D, Cízek L: Detection of insulin resistance by simple quantitative sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 2002, 87:144-147
36. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M: Plasma leptin and insulin relationship in obese and nonobese humans. Diabetes 1996, 45:695-698
37. Considin RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295
38. Caprio S, Tamborlane WV, Silver D, Robinson C, Leibel R, McCarthy S, Grozman A, Belous A, Maggs D, Sherwin RS: Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol 1996, 271:623-630
39. Ryan AS, Elahi D: The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin level: its relationships with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab 1996, 81:4433-4438
40. Sumner AE, Falkner B, Kushner H, Considine RV: Relationship of leptin concentration to gender, menopause, age, diabetes, and fat mass in African Americans. Obesity Research 1998, 6:128-133
41. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE: The concurrent accumulation of intra-abdominal and subcutanous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes 2002, 51:1005-1015
42. Mendoza-Núnez VM, García-Sanchéz A, Sánchéz-Rodrigéz M, Galván-Duarte RE, Fonseca-Yerena ME: Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. Obesity Research 2002, 10:253-259
43. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91
44. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 1996, 259:87-91
45. Hotamisligil GS: Mechanisms of TNFα-induced insulin resistance. J Exp Clin Endocrinol Diabetes 1999, 107:119-125
46. Stephens JM, Lee JL, Pilch PF: Tumor necrosis factor-alpha induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT 4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997, 272:971-976
47. Hoffstedt J, Eriksson P, Hellström L, Rössner S, Rydén M, Arner P: Excessive fat accumulation is associated with the TNFα-308 G/A promoter polymorphism in women but not in men. Diabetologia 2000, 43:117-120
48. Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M: Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetes mellitus. Diabetes Metab 2000, 26:178-182
49. Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ: Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 1999, 7:355-362
50. Schlame M, Hostetler KY: Cardiolipin synthase from mammalian mitochondria. Biochimica and Biophysica Acta 1997, 1348:207-213
51. Vaarala O: Antiphospholipid antibodies and myocardial infarction. Lupus 1998, 7(Suppl 2):S132-S134
52. Bonen A, Luiken JJ, Liu S, Dyck DJ, Kiens B, Kristiansen S, Turcotte LP, Van Der Vusse GJ, Glatz JF: Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol 1998, 275(3 Pt 1):E471-E478
53. Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C: Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol 1998, 274(2 Pt 1):E210-E217